

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.25667742 |
| 2 | negative regulation of cell killing (GO:0031342) | 5.00033274 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.00033274 |
| 4 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.38566005 |
| 5 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.32406581 |
| 6 | regulation of gamma-delta T cell activation (GO:0046643) | 4.29549631 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.18505789 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.14842605 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.08771775 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.07857366 |
| 11 | negative thymic T cell selection (GO:0045060) | 3.97062613 |
| 12 | thymic T cell selection (GO:0045061) | 3.80693616 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.79238838 |
| 14 | negative T cell selection (GO:0043383) | 3.77988394 |
| 15 | positive T cell selection (GO:0043368) | 3.59217986 |
| 16 | activated T cell proliferation (GO:0050798) | 3.55884205 |
| 17 | T cell selection (GO:0045058) | 3.49350823 |
| 18 | leukocyte aggregation (GO:0070486) | 3.40169568 |
| 19 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.34614948 |
| 20 | regulation of ARF protein signal transduction (GO:0032012) | 3.31574446 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.24268725 |
| 22 | regulation of ARF GTPase activity (GO:0032312) | 3.21119921 |
| 23 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.21002322 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.19897349 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.19897349 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.19897349 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.19897349 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.19897349 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.19897349 |
| 30 | response to interleukin-15 (GO:0070672) | 3.18471997 |
| 31 | detection of bacterium (GO:0016045) | 3.13831224 |
| 32 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.12565234 |
| 33 | detection of other organism (GO:0098543) | 3.10208546 |
| 34 | macrophage activation involved in immune response (GO:0002281) | 3.09708219 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.08379190 |
| 36 | B cell receptor signaling pathway (GO:0050853) | 3.01505766 |
| 37 | mannose metabolic process (GO:0006013) | 2.99736674 |
| 38 | response to muramyl dipeptide (GO:0032495) | 2.88100177 |
| 39 | signal complex assembly (GO:0007172) | 2.87889229 |
| 40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86882280 |
| 41 | positive regulation of granulocyte differentiation (GO:0030854) | 2.83583203 |
| 42 | positive regulation of Rap GTPase activity (GO:0032854) | 2.81082843 |
| 43 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.74482288 |
| 44 | histone H3-K36 demethylation (GO:0070544) | 2.74370650 |
| 45 | regulation of T cell tolerance induction (GO:0002664) | 2.74111004 |
| 46 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.74013176 |
| 47 | germinal center formation (GO:0002467) | 2.72902936 |
| 48 | regulation of tolerance induction (GO:0002643) | 2.69499215 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 2.64266832 |
| 50 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.63505237 |
| 51 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.62893177 |
| 52 | cellular response to interleukin-15 (GO:0071350) | 2.62008342 |
| 53 | positive regulation of B cell differentiation (GO:0045579) | 2.61423317 |
| 54 | tolerance induction (GO:0002507) | 2.60750534 |
| 55 | detection of external biotic stimulus (GO:0098581) | 2.59625923 |
| 56 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.59106941 |
| 57 | response to type I interferon (GO:0034340) | 2.56798681 |
| 58 | regulation of B cell differentiation (GO:0045577) | 2.55652763 |
| 59 | negative regulation of type 2 immune response (GO:0002829) | 2.52134665 |
| 60 | histone H3-K4 trimethylation (GO:0080182) | 2.51562902 |
| 61 | cellular response to type I interferon (GO:0071357) | 2.51040309 |
| 62 | type I interferon signaling pathway (GO:0060337) | 2.51040309 |
| 63 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.48910536 |
| 64 | regulation of granulocyte differentiation (GO:0030852) | 2.48212955 |
| 65 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.48114111 |
| 66 | response to host immune response (GO:0052572) | 2.48114111 |
| 67 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.47355973 |
| 68 | response to host (GO:0075136) | 2.47355973 |
| 69 | response to host defenses (GO:0052200) | 2.47355973 |
| 70 | positive regulation of histone deacetylation (GO:0031065) | 2.44757183 |
| 71 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.43121010 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.43121010 |
| 73 | response to laminar fluid shear stress (GO:0034616) | 2.39249309 |
| 74 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.38617130 |
| 75 | regulation of Rap GTPase activity (GO:0032317) | 2.34377682 |
| 76 | positive regulation of tolerance induction (GO:0002645) | 2.31323516 |
| 77 | immunoglobulin mediated immune response (GO:0016064) | 2.30891078 |
| 78 | T cell homeostasis (GO:0043029) | 2.29566881 |
| 79 | histone H4 deacetylation (GO:0070933) | 2.27772752 |
| 80 | detection of biotic stimulus (GO:0009595) | 2.27429087 |
| 81 | histone lysine demethylation (GO:0070076) | 2.26218045 |
| 82 | positive regulation of protein deacetylation (GO:0090312) | 2.23359496 |
| 83 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.23339231 |
| 84 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.22837091 |
| 85 | histone H3-K9 demethylation (GO:0033169) | 2.21835086 |
| 86 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.21560849 |
| 87 | detection of molecule of bacterial origin (GO:0032490) | 2.20593211 |
| 88 | activation of JUN kinase activity (GO:0007257) | 2.19969750 |
| 89 | regulation of regulatory T cell differentiation (GO:0045589) | 2.19697322 |
| 90 | negative regulation of innate immune response (GO:0045824) | 2.19535856 |
| 91 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.19479949 |
| 92 | regulation of leukocyte degranulation (GO:0043300) | 2.18619676 |
| 93 | neutrophil activation involved in immune response (GO:0002283) | 2.18594105 |
| 94 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.17888840 |
| 95 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.17888840 |
| 96 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.17536395 |
| 97 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.16459003 |
| 98 | cellular extravasation (GO:0045123) | 2.14418940 |
| 99 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.14246635 |
| 100 | regulation of beta-amyloid formation (GO:1902003) | 2.14182324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.23872791 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.11721224 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.92044060 |
| 4 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.80996982 |
| 5 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41017042 |
| 6 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.36791190 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.34716332 |
| 8 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.33404372 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.25943427 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.25470813 |
| 11 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.19827470 |
| 12 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.19266970 |
| 13 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.13621652 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.07324653 |
| 15 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.06674898 |
| 16 | MYC_22102868_ChIP-Seq_BL_Human | 2.06435368 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.89910233 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.89224811 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88045167 |
| 20 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.87995571 |
| 21 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.85109494 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 1.84334757 |
| 23 | KDM2B_26808549_Chip-Seq_K562_Human | 1.80218300 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.78116689 |
| 25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.77932088 |
| 26 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.76311218 |
| 27 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.75043627 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74039195 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73784359 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67453538 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64682628 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63736759 |
| 33 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.61638997 |
| 34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.61616958 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59035390 |
| 36 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.56615728 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.56318843 |
| 38 | MAF_26560356_Chip-Seq_TH2_Human | 1.54630832 |
| 39 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.54104861 |
| 40 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.50918350 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50672981 |
| 42 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.48357697 |
| 43 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.47925581 |
| 44 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.43433326 |
| 45 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.42117736 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.38329748 |
| 47 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36966700 |
| 48 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.35378137 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.33006790 |
| 50 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30659513 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.29210139 |
| 52 | P68_20966046_ChIP-Seq_HELA_Human | 1.26172580 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25531068 |
| 54 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.21832106 |
| 55 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.21719910 |
| 56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19122018 |
| 57 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19082217 |
| 58 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.19043372 |
| 59 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.16814803 |
| 60 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.16682408 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16588478 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.14359382 |
| 63 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.13530584 |
| 64 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13502407 |
| 65 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.13047091 |
| 66 | MYB_26560356_Chip-Seq_TH2_Human | 1.11042572 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.09546486 |
| 68 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08395406 |
| 69 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07904104 |
| 70 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.07565318 |
| 71 | MYB_26560356_Chip-Seq_TH1_Human | 1.05795772 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.03834162 |
| 73 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.02101112 |
| 74 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.01797173 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01705854 |
| 76 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.01067369 |
| 77 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00541339 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00094157 |
| 79 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.99717409 |
| 80 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99189284 |
| 81 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98820452 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95920205 |
| 83 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.95577344 |
| 84 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.94837393 |
| 85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94375295 |
| 86 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.94146723 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93712083 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.93703531 |
| 89 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93691880 |
| 90 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91550603 |
| 91 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.91348843 |
| 92 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.91048264 |
| 93 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90117438 |
| 94 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88828698 |
| 95 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88431213 |
| 96 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.88030248 |
| 97 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87923136 |
| 98 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.87333074 |
| 99 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.87327725 |
| 100 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.86718282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003436_decreased_susceptibility_to | 3.30990690 |
| 2 | MP0003172_abnormal_lysosome_physiology | 2.96517099 |
| 3 | MP0003763_abnormal_thymus_physiology | 2.87138923 |
| 4 | MP0003724_increased_susceptibility_to | 2.84340265 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.63531687 |
| 6 | MP0003303_peritoneal_inflammation | 2.51441337 |
| 7 | MP0001800_abnormal_humoral_immune | 2.44281311 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.40767864 |
| 9 | MP0004381_abnormal_hair_follicle | 2.35615214 |
| 10 | MP0001790_abnormal_immune_system | 2.33131849 |
| 11 | MP0005387_immune_system_phenotype | 2.33131849 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.12661447 |
| 13 | MP0008260_abnormal_autophagy | 2.04079543 |
| 14 | MP0002419_abnormal_innate_immunity | 2.03648804 |
| 15 | MP0005025_abnormal_response_to | 2.01692614 |
| 16 | MP0002723_abnormal_immune_serum | 1.93828481 |
| 17 | MP0009278_abnormal_bone_marrow | 1.93676883 |
| 18 | MP0003866_abnormal_defecation | 1.90125805 |
| 19 | MP0002420_abnormal_adaptive_immunity | 1.89576046 |
| 20 | MP0001819_abnormal_immune_cell | 1.86712159 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.83371016 |
| 22 | MP0003690_abnormal_glial_cell | 1.83141676 |
| 23 | MP0004859_abnormal_synaptic_plasticity | 1.79758710 |
| 24 | MP0002452_abnormal_antigen_presenting | 1.75630143 |
| 25 | MP0001958_emphysema | 1.74865946 |
| 26 | MP0005671_abnormal_response_to | 1.70002754 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.66956119 |
| 28 | MP0002933_joint_inflammation | 1.66429700 |
| 29 | MP0004947_skin_inflammation | 1.64991837 |
| 30 | MP0002396_abnormal_hematopoietic_system | 1.63666928 |
| 31 | MP0001873_stomach_inflammation | 1.63419828 |
| 32 | MP0002405_respiratory_system_inflammati | 1.62114664 |
| 33 | MP0010155_abnormal_intestine_physiology | 1.61806459 |
| 34 | MP0003279_aneurysm | 1.61724325 |
| 35 | MP0000685_abnormal_immune_system | 1.60208322 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 1.58232463 |
| 37 | MP0003191_abnormal_cellular_cholesterol | 1.56199809 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.50853760 |
| 39 | MP0004858_abnormal_nervous_system | 1.50554263 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.48166988 |
| 41 | MP0000716_abnormal_immune_system | 1.47563592 |
| 42 | MP0002398_abnormal_bone_marrow | 1.44459631 |
| 43 | MP0005409_darkened_coat_color | 1.37253778 |
| 44 | MP0004130_abnormal_muscle_cell | 1.35650215 |
| 45 | MP0000703_abnormal_thymus_morphology | 1.35556434 |
| 46 | MP0006082_CNS_inflammation | 1.34008618 |
| 47 | MP0003045_fibrosis | 1.26516626 |
| 48 | MP0003329_amyloid_beta_deposits | 1.26465344 |
| 49 | MP0003091_abnormal_cell_migration | 1.25066044 |
| 50 | MP0002822_catalepsy | 1.24998390 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.19238379 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.17755642 |
| 53 | MP0001851_eye_inflammation | 1.11034161 |
| 54 | MP0003828_pulmonary_edema | 1.09160184 |
| 55 | MP0000689_abnormal_spleen_morphology | 1.08212099 |
| 56 | MP0002249_abnormal_larynx_morphology | 1.07295017 |
| 57 | MP0001986_abnormal_taste_sensitivity | 1.06357055 |
| 58 | MP0000604_amyloidosis | 1.06081517 |
| 59 | MP0009785_altered_susceptibility_to | 1.05802638 |
| 60 | MP0002722_abnormal_immune_system | 1.05252794 |
| 61 | MP0002009_preneoplasia | 1.05103009 |
| 62 | MP0001845_abnormal_inflammatory_respons | 1.05061515 |
| 63 | MP0001849_ear_inflammation | 1.03566296 |
| 64 | MP0004808_abnormal_hematopoietic_stem | 1.03129419 |
| 65 | MP0002429_abnormal_blood_cell | 1.01482934 |
| 66 | MP0008961_abnormal_basal_metabolism | 1.00599631 |
| 67 | MP0005075_abnormal_melanosome_morpholog | 0.96896562 |
| 68 | MP0005397_hematopoietic_system_phenotyp | 0.96728879 |
| 69 | MP0001545_abnormal_hematopoietic_system | 0.96728879 |
| 70 | MP0008569_lethality_at_weaning | 0.95054125 |
| 71 | MP0004510_myositis | 0.94872856 |
| 72 | MP0001502_abnormal_circadian_rhythm | 0.92755459 |
| 73 | MP0004883_abnormal_blood_vessel | 0.92064550 |
| 74 | MP0003075_altered_response_to | 0.91433417 |
| 75 | MP0009333_abnormal_splenocyte_physiolog | 0.89868550 |
| 76 | MP0000920_abnormal_myelination | 0.89085659 |
| 77 | MP0002132_abnormal_respiratory_system | 0.87995326 |
| 78 | MP0002653_abnormal_ependyma_morphology | 0.86525864 |
| 79 | MP0001348_abnormal_lacrimal_gland | 0.85620955 |
| 80 | MP0005451_abnormal_body_composition | 0.85503735 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 0.85263355 |
| 82 | MP0002166_altered_tumor_susceptibility | 0.85151017 |
| 83 | MP0005310_abnormal_salivary_gland | 0.84494058 |
| 84 | MP0005423_abnormal_somatic_nervous | 0.84168155 |
| 85 | MP0008874_decreased_physiological_sensi | 0.84004380 |
| 86 | MP0003635_abnormal_synaptic_transmissio | 0.83795765 |
| 87 | MP0005390_skeleton_phenotype | 0.81076174 |
| 88 | MP0005248_abnormal_Harderian_gland | 0.80955538 |
| 89 | MP0000015_abnormal_ear_pigmentation | 0.79971231 |
| 90 | MP0009384_cardiac_valve_regurgitation | 0.79390036 |
| 91 | MP0002063_abnormal_learning/memory/cond | 0.77971492 |
| 92 | MP0005166_decreased_susceptibility_to | 0.75135117 |
| 93 | MP0005503_abnormal_tendon_morphology | 0.74671049 |
| 94 | MP0005535_abnormal_body_temperature | 0.74477271 |
| 95 | MP0000858_altered_metastatic_potential | 0.74351424 |
| 96 | MP0001663_abnormal_digestive_system | 0.73528563 |
| 97 | MP0000249_abnormal_blood_vessel | 0.73430856 |
| 98 | MP0003879_abnormal_hair_cell | 0.72753837 |
| 99 | MP0008469_abnormal_protein_level | 0.72656313 |
| 100 | MP0001853_heart_inflammation | 0.70831756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Obstructive sleep apnea (HP:0002870) | 4.58886144 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.14668419 |
| 3 | Colitis (HP:0002583) | 3.43518137 |
| 4 | Papilledema (HP:0001085) | 3.38352261 |
| 5 | Abnormality of the fingertips (HP:0001211) | 3.32001381 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.14510798 |
| 7 | Broad face (HP:0000283) | 3.13837293 |
| 8 | Myositis (HP:0100614) | 3.09436111 |
| 9 | Panhypogammaglobulinemia (HP:0003139) | 3.04575557 |
| 10 | Gastrointestinal inflammation (HP:0004386) | 3.00086413 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.98988475 |
| 12 | Recurrent bacterial skin infections (HP:0005406) | 2.96623017 |
| 13 | Inflammation of the large intestine (HP:0002037) | 2.94225767 |
| 14 | Recurrent fungal infections (HP:0002841) | 2.91272004 |
| 15 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.85697208 |
| 16 | Recurrent cutaneous fungal infections (HP:0011370) | 2.85697208 |
| 17 | Gingivitis (HP:0000230) | 2.82472357 |
| 18 | Increased IgE level (HP:0003212) | 2.72669298 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 2.64573534 |
| 20 | Nasal polyposis (HP:0100582) | 2.60954468 |
| 21 | Spontaneous hematomas (HP:0007420) | 2.57954856 |
| 22 | Orchitis (HP:0100796) | 2.54635690 |
| 23 | Cerebral aneurysm (HP:0004944) | 2.52933069 |
| 24 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52335943 |
| 25 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.47066206 |
| 26 | Meningitis (HP:0001287) | 2.46967404 |
| 27 | Abnormality of the nasal mucosa (HP:0000433) | 2.44087356 |
| 28 | Prolonged bleeding time (HP:0003010) | 2.40597697 |
| 29 | Supranuclear gaze palsy (HP:0000605) | 2.38600370 |
| 30 | Cellulitis (HP:0100658) | 2.37288394 |
| 31 | Agammaglobulinemia (HP:0004432) | 2.33090791 |
| 32 | Recurrent skin infections (HP:0001581) | 2.32339091 |
| 33 | Genetic anticipation (HP:0003743) | 2.32291510 |
| 34 | Abnormality of macrophages (HP:0004311) | 2.31361374 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 2.28741374 |
| 36 | Retrobulbar optic neuritis (HP:0100654) | 2.28358060 |
| 37 | Optic neuritis (HP:0100653) | 2.28358060 |
| 38 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.18699487 |
| 39 | Thin bony cortex (HP:0002753) | 2.18687398 |
| 40 | Chest pain (HP:0100749) | 2.17123695 |
| 41 | Ankle clonus (HP:0011448) | 2.15342272 |
| 42 | Recurrent bronchitis (HP:0002837) | 2.13904747 |
| 43 | Absent/shortened dynein arms (HP:0200106) | 2.10890302 |
| 44 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.10890302 |
| 45 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.09401127 |
| 46 | Mucopolysacchariduria (HP:0008155) | 2.09401127 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.09130491 |
| 48 | Obstructive lung disease (HP:0006536) | 2.09130491 |
| 49 | Recurrent viral infections (HP:0004429) | 2.08200446 |
| 50 | Slow saccadic eye movements (HP:0000514) | 2.06407218 |
| 51 | Vasculitis (HP:0002633) | 2.06084840 |
| 52 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.05033404 |
| 53 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.05033404 |
| 54 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.05033404 |
| 55 | Encephalitis (HP:0002383) | 2.01264800 |
| 56 | Hemoptysis (HP:0002105) | 2.00860922 |
| 57 | Spinal canal stenosis (HP:0003416) | 2.00621192 |
| 58 | Emphysema (HP:0002097) | 1.99440623 |
| 59 | Dysostosis multiplex (HP:0000943) | 1.97422438 |
| 60 | Neoplasm of the heart (HP:0100544) | 1.96767257 |
| 61 | Abnormality of binocular vision (HP:0011514) | 1.96498633 |
| 62 | Diplopia (HP:0000651) | 1.96498633 |
| 63 | Stomatitis (HP:0010280) | 1.95246696 |
| 64 | Cervical subluxation (HP:0003308) | 1.93075056 |
| 65 | Aneurysm (HP:0002617) | 1.90338477 |
| 66 | Viral hepatitis (HP:0006562) | 1.90244056 |
| 67 | Chronic otitis media (HP:0000389) | 1.89012468 |
| 68 | T lymphocytopenia (HP:0005403) | 1.88800987 |
| 69 | Sleep apnea (HP:0010535) | 1.88159515 |
| 70 | Pustule (HP:0200039) | 1.87594173 |
| 71 | Abnormal ciliary motility (HP:0012262) | 1.87338854 |
| 72 | Neurofibrillary tangles (HP:0002185) | 1.86156478 |
| 73 | Pulmonary infiltrates (HP:0002113) | 1.84699432 |
| 74 | Annular pancreas (HP:0001734) | 1.84500459 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 1.81501100 |
| 76 | Restrictive lung disease (HP:0002091) | 1.77309047 |
| 77 | Epistaxis (HP:0000421) | 1.74313272 |
| 78 | Aortic aneurysm (HP:0004942) | 1.73125055 |
| 79 | Hemiplegia (HP:0002301) | 1.71889315 |
| 80 | Recurrent sinusitis (HP:0011108) | 1.70737619 |
| 81 | Mitral regurgitation (HP:0001653) | 1.69364148 |
| 82 | Polygenic inheritance (HP:0010982) | 1.67012898 |
| 83 | Dilatation of the ascending aorta (HP:0005111) | 1.65361441 |
| 84 | Spondylolisthesis (HP:0003302) | 1.64958224 |
| 85 | J-shaped sella turcica (HP:0002680) | 1.62863687 |
| 86 | Asymmetric septal hypertrophy (HP:0001670) | 1.62540596 |
| 87 | Gingival bleeding (HP:0000225) | 1.62364991 |
| 88 | Interstitial pulmonary disease (HP:0006530) | 1.61364258 |
| 89 | Pulmonary embolism (HP:0002204) | 1.61003745 |
| 90 | Metaphyseal cupping (HP:0003021) | 1.60943609 |
| 91 | Abnormality of the columella (HP:0009929) | 1.60320776 |
| 92 | Hemorrhage of the eye (HP:0011885) | 1.60255464 |
| 93 | Neuronal loss in central nervous system (HP:0002529) | 1.60093829 |
| 94 | Increased CSF protein (HP:0002922) | 1.58948853 |
| 95 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.58212031 |
| 96 | Recurrent otitis media (HP:0000403) | 1.57691523 |
| 97 | Verrucae (HP:0200043) | 1.57238536 |
| 98 | Papilloma (HP:0012740) | 1.57238536 |
| 99 | Abnormality of T cell number (HP:0011839) | 1.56667085 |
| 100 | Dislocated radial head (HP:0003083) | 1.55965287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 3.07139295 |
| 2 | TRIB3 | 2.92884825 |
| 3 | RIPK4 | 2.67229305 |
| 4 | TNK2 | 2.62429228 |
| 5 | ERN1 | 2.41907345 |
| 6 | PRPF4B | 2.34817636 |
| 7 | MARK2 | 2.12859676 |
| 8 | TYK2 | 2.11091788 |
| 9 | EPHB1 | 1.94476806 |
| 10 | FES | 1.93453940 |
| 11 | BLK | 1.84826357 |
| 12 | SIK1 | 1.84396462 |
| 13 | ZAP70 | 1.72337444 |
| 14 | MAP2K3 | 1.67761167 |
| 15 | TXK | 1.61309768 |
| 16 | MAPK15 | 1.60005830 |
| 17 | MAP3K13 | 1.55802164 |
| 18 | SIK2 | 1.55131391 |
| 19 | MAP3K7 | 1.54323023 |
| 20 | CDC42BPA | 1.52003792 |
| 21 | GRK6 | 1.48665048 |
| 22 | CSK | 1.44970336 |
| 23 | CAMKK1 | 1.42139602 |
| 24 | CDK12 | 1.40668561 |
| 25 | JAK1 | 1.40664173 |
| 26 | FGFR4 | 1.40173200 |
| 27 | BTK | 1.40121243 |
| 28 | RIPK1 | 1.33077462 |
| 29 | PRKD2 | 1.30856280 |
| 30 | TYRO3 | 1.21453413 |
| 31 | HCK | 1.20686387 |
| 32 | MAP3K6 | 1.19223635 |
| 33 | IRAK4 | 1.18227228 |
| 34 | TAOK1 | 1.16232122 |
| 35 | PKN2 | 1.11891774 |
| 36 | SYK | 1.11885696 |
| 37 | JAK3 | 1.10464340 |
| 38 | IKBKE | 1.10152175 |
| 39 | HIPK2 | 1.09003908 |
| 40 | MAPK7 | 1.06888420 |
| 41 | ITK | 1.05326408 |
| 42 | MAP3K3 | 1.01390895 |
| 43 | MAPK12 | 1.00850056 |
| 44 | SIK3 | 0.97640191 |
| 45 | MAP3K10 | 0.95089773 |
| 46 | PRKD3 | 0.94593893 |
| 47 | TBK1 | 0.92771512 |
| 48 | PTK6 | 0.90431878 |
| 49 | FGFR3 | 0.89295982 |
| 50 | MAP2K6 | 0.88779999 |
| 51 | STK38 | 0.88037306 |
| 52 | LCK | 0.87828595 |
| 53 | RET | 0.87393691 |
| 54 | SMG1 | 0.87059426 |
| 55 | KIT | 0.84969768 |
| 56 | CSF1R | 0.84950713 |
| 57 | FGFR2 | 0.81934952 |
| 58 | RPS6KA2 | 0.81816439 |
| 59 | SGK2 | 0.81386587 |
| 60 | PDK1 | 0.80987629 |
| 61 | PTK2B | 0.80429724 |
| 62 | SGK3 | 0.80060574 |
| 63 | PRKCH | 0.79636933 |
| 64 | JAK2 | 0.79463345 |
| 65 | NTRK2 | 0.78126068 |
| 66 | MAP3K1 | 0.77632910 |
| 67 | DYRK1B | 0.75354832 |
| 68 | KSR2 | 0.73798723 |
| 69 | MAP3K11 | 0.73730028 |
| 70 | SGK494 | 0.71431078 |
| 71 | SGK223 | 0.71431078 |
| 72 | PDGFRB | 0.71249095 |
| 73 | NTRK3 | 0.70899558 |
| 74 | PDPK1 | 0.69835279 |
| 75 | LYN | 0.67999735 |
| 76 | EPHA3 | 0.67700133 |
| 77 | ICK | 0.67257220 |
| 78 | FYN | 0.67208912 |
| 79 | RPS6KL1 | 0.66973440 |
| 80 | RPS6KC1 | 0.66973440 |
| 81 | STK11 | 0.66247115 |
| 82 | MAP3K14 | 0.63399837 |
| 83 | MARK3 | 0.61965431 |
| 84 | UHMK1 | 0.60740226 |
| 85 | MAP2K4 | 0.60016236 |
| 86 | PDGFRA | 0.59809507 |
| 87 | WNK1 | 0.58511233 |
| 88 | CAMKK2 | 0.56668761 |
| 89 | TTN | 0.56291073 |
| 90 | RPS6KA6 | 0.54940967 |
| 91 | TAOK3 | 0.54692393 |
| 92 | MTOR | 0.54315104 |
| 93 | ERBB2 | 0.53891996 |
| 94 | CAMK4 | 0.53592841 |
| 95 | MAP2K2 | 0.51495434 |
| 96 | LRRK2 | 0.50474202 |
| 97 | PRKD1 | 0.49963960 |
| 98 | NLK | 0.49647238 |
| 99 | EEF2K | 0.47833809 |
| 100 | CAMK1 | 0.46426953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.87666930 |
| 2 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.86217802 |
| 3 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.72734567 |
| 4 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.66193796 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 1.62850801 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59680588 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.59246970 |
| 8 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.58005096 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54353820 |
| 10 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.46067734 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.44229879 |
| 12 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.38793776 |
| 13 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.37200164 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.36360993 |
| 15 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.35416044 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.34624379 |
| 17 | Allograft rejection_Homo sapiens_hsa05330 | 1.34443383 |
| 18 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.33667538 |
| 19 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.31016602 |
| 20 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.28843521 |
| 21 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23399552 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.17703296 |
| 23 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.17435359 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17280242 |
| 25 | Tuberculosis_Homo sapiens_hsa05152 | 1.16720810 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15839928 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15787732 |
| 28 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.10538475 |
| 29 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.09595550 |
| 30 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09332644 |
| 31 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.07733277 |
| 32 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07533969 |
| 33 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06503801 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06106718 |
| 35 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05852016 |
| 36 | Long-term potentiation_Homo sapiens_hsa04720 | 1.05399667 |
| 37 | Platelet activation_Homo sapiens_hsa04611 | 1.05021793 |
| 38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04169425 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.03818205 |
| 40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02850860 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.00357842 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 0.99758562 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99700341 |
| 44 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99107262 |
| 45 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.98062513 |
| 46 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.97376727 |
| 47 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97169197 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96586692 |
| 49 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.95044691 |
| 50 | Measles_Homo sapiens_hsa05162 | 0.94624889 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.94605631 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.93601961 |
| 53 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.91607114 |
| 54 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89953652 |
| 55 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88938853 |
| 56 | Glioma_Homo sapiens_hsa05214 | 0.86858125 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86198131 |
| 58 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.85035171 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.84862852 |
| 60 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.84024771 |
| 61 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82643671 |
| 62 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82356193 |
| 63 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.81819102 |
| 64 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.81292661 |
| 65 | Hepatitis B_Homo sapiens_hsa05161 | 0.81120519 |
| 66 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.80672875 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79862213 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.79455164 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.78662781 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.77387591 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 0.77273839 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76002277 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.75581487 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.74659229 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.74390344 |
| 76 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.73455409 |
| 77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72824907 |
| 78 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70358329 |
| 79 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.69116937 |
| 80 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.68499073 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67572100 |
| 82 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65925570 |
| 83 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.65216377 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.64710979 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.63282376 |
| 86 | Circadian entrainment_Homo sapiens_hsa04713 | 0.62451318 |
| 87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62450327 |
| 88 | ABC transporters_Homo sapiens_hsa02010 | 0.62077598 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61937076 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61233980 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.60993370 |
| 92 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59274707 |
| 93 | Prostate cancer_Homo sapiens_hsa05215 | 0.58840783 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.58637617 |
| 95 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.56145798 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.55373579 |
| 97 | Insulin secretion_Homo sapiens_hsa04911 | 0.53886777 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53707597 |
| 99 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.53152754 |
| 100 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.52058787 |

